Senolytic Therapeutics Overview

  • Founded
  • 2017
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $500K
Latest Deal Amount

Senolytic Therapeutics General Information


Operator of a pharmaceutical company intended to develop medicines and therapeutics for patients affected by age-related diseases. The company's medicines target and eliminate damaged cells, enabling healthcare providers to improve the lives of those affected by diseases associated with aging.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Barcelona Science Park
  • Calle Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Senolytic Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 07-Aug-2017 $500K 00000 Completed Stealth
To view Senolytic Therapeutics’s complete valuation and funding history, request access »

Senolytic Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Marc Castelltort Ph.D Co-Founder, Board Member & Chief Executive Officer
Timothy Cash Chief Scientific Officer
Joserra Murguia Co-Founder, Scientific Co-Founder & Advisor
Ramón Martínez-Máñez Ph.D Scientific Co-Founder & Advisor
Brian Malone Chief Financial Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Senolytic Therapeutics Board Members (4)

Name Representing Role Since
David Sinclair Ph.D Self Scientific Co-Founder, Board Member & Advisor 000 0000
Lawrence Gozlan Self Chairman 000 0000
Marc Castelltort Ph.D Senolytic Therapeutics Co-Founder, Board Member & Chief Executive Officer 000 0000
Tristan Edwards Self Board Member 000 0000
To view Senolytic Therapeutics’s complete board members history, request access »